bullish
IVL: Value Accretion from Oxiteno Acquisition
We have a positive view on IVL’s new acquisition of Oxiteno given the inexpensive deal, earnings accretion and synergy benefits. We maintain the BUY recommendation based on a target price to Bt46.0,
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Pi Securities PCL, Thailand
Leading, full-service investment firm in Thailand
Price Chart(Sign Up to Access)
- IVL : Strong IOD Performance Drove 2Q22 Profit to New High11 Aug 2022
- IVL: Solid PET Performance Drove 1Q22 Profit13 May 2022
- IVL: Oxiteno Earnings to Kick in by 2Q2208 Apr 2022
- IVL: Solid Outlook in 2Q21 from Seasonality07 May 2021
- IVL: Expect Strong Earnings Momentum in 1Q21 and Peak in 2Q2101 Mar 2021
- IVL: Expects a Gradual Recovery in 4Q2010 Nov 2020
x